Ethics & Informed Consent: Prospective Cohort Study (Brazil)
A detailed academic review of the ethical submission protocol, informed consent prerequisites, and reporting standards for conducting a Prospective Cohort Study within the regulatory framework of Brazil.
1. Ethical Principles & Legislative Framework
In research involving human participants, securing ethical clearance is a critical first step. For a Prospective Cohort Study being conducted in Brazil, study designs must align with the primary regulatory legislation: Resolution CNS 466/12 & Resolution CNS 510/16. This statutory framework ensures participant welfare, confidentiality, and voluntary involvement are protected.
National Ethics Board Clearance Pathway
In Brazil, human research is governed by the CEP/CONEP system, utilising the national Plataforma Brasil for protocol submission. Social science studies follow Resolution CNS 510/16, while biomedical research is regulated under Resolution CNS 466/12. Data collection and processing must strictly align with the Lei Geral de Proteção de Dados (LGPD), securing written informed consent (TCLE) and detailing data security measures to prevent administrative and legal penalties.
Administrative review and formal approval are managed by a local or regional Comitê de Ética em Pesquisa (CEP / CONEP System). Researchers must secure full approval or a formal exemption certificate from this board before recruiting any participants or commencing data collection.
2. Study Design Elements & Reporting Integrity
For a Prospective Cohort Study, the review board places significant focus on methodological transparency. The application must outline the research rationale, recruitment protocols, inclusion and exclusion criteria, and data protection measures.
Study Classification: Minimal to Moderate Risk (Observational)
Prospective studies track participants over years. Informed consent must outline participant options regarding long-term contact, data storage limits, and protocols for re-contacting families.
To guarantee academic integrity and reproducibility, the study report and subsequent publications should follow the internationally recognised reporting standard: STROBE guidelines.
Special Directive: Observational Study Protocols
As an observational or non-interventional design, the ethics board primarily focuses on data privacy, secure pseudonymisation, and informed consent. If you are conducting retrospective database research, you may apply for a waiver of consent, provided participant risk is minimised.
3. Informed Consent & Information Sheet Guidelines
A robust participant information sheet and informed consent form are critical parts of the ethical application. Ensure your documentation incorporates the following components:
Design-Specific Consent Focus Areas
Informed permission for prospective follow-up surveys, medical registry linkages, and re-contact options.
- Plain Language Explanations: Avoid complex medical or technical terminology. Ensure readability matches the general population.
- Voluntary Participation: Explicitly state that participation is entirely voluntary and that individuals can withdraw at any time without negative consequences.
- Confidentiality & Data Controls: Explain how participant data will be anonymised or pseudonymised, who will have access to it, and how long it will be securely retained under Lei Geral de Proteção de Dados (LGPD).
- Risk/Benefit Disclosure: Clearly list any potential risks, discomforts, or direct benefits associated with participation in the study.
- Ethics Board Contact Information: Provide the contact details of the reviewing Comitê de Ética em Pesquisa (CEP / CONEP System) so participants can reach out if they have questions or concerns.
Research Ethics, Clinical Trials & Institutional Governance
Passive tracking in this Prospective Cohort Study in Brazil relies on beneficence in research ethics to balance data utility with privacy. Observational registries in Brazil must pay special attention to vulnerable populations research ethics when storing health metrics. Observational researchers must submit a secure informed consent template research form detailing electronic data pathways. Depending on the de-identification pipeline, some database studies may qualify under irb exempt research criteria. Without any animal protocols under the animal research ethics 3rs, the application focuses on human clinical data security. Ethical oversight committees in Brazil audit the study's consent registry periodically to verify compliance with national legal statutes.
4. Regulatory Checklist Table
To streamline your ethical review submission, use the structured alignment checklist below:
| Requirement | Comitê de Ética em Pesquisa (CEP / CONEP System) Standard | STROBE guidelines Standard |
|---|---|---|
| Consent Form | Signed and dated prior to study activity. Focus: Informed permission for prospective follow-up surveys. | Fully documented recruitment and consent paths. |
| Risk Management | Comprehensive risk mitigation plan. Implementing role-based access controls for databases and isolating pseudonymised key files. | Adverse events reporting strategy. |
| Data Retention | Compliance with local data protection rules (Lei Geral de Proteção de Dados (LGPD)). | Provision of open-data options where possible. |
5. Academic & Research Infrastructure Matrix (Brazil)
The following authenticated registry lists top scientific organizations, clinical laboratories, and research hospitals in Brazil mapped via the Research Organization Registry (ROR) standards-compliance framework.
| Organization Name | Sector Type | Registry Identification |
|---|---|---|
| Instituto Vital Brazil (Brazil) | company | ROR ID |
| Petrobras (Brazil) | company | ROR IDWikidata/Wiki |
| Estácio (Brazil) | company | ROR IDWikidata/Wiki |
| Anhanguera (Brazil) | company | ROR ID |
| TOTVS (Brazil) | company | ROR ID |
| AES (Brazil) | company | ROR IDWikidata/Wiki |
| DuPont (Brazil) | company | ROR IDWikidata/Wiki |
| Embraco (Brazil) | company | ROR IDWikidata/Wiki |
| Folha (Brazil) | company | ROR IDWikidata/Wiki |
| Libbs (Brazil) | company | ROR ID |
| Brf (Brazil) | company | ROR IDWikidata/Wiki |
| Sanofi (Brazil) | company | ROR IDWikidata/Wiki |
| Meritor (Brazil) | company | ROR IDWikidata/Wiki |
| Teccampos (Brazil) | company | ROR ID |
| Biominas (Brazil) | company | ROR ID |
6. Frequently Asked Questions
How long does the review process normally take?
Review timelines depend on the volume of applications and whether your proposal qualifies for expedited review. On average, a standard review by an ethics board in Brazil takes between 4 to 8 weeks.
Can we use digital signatures for informed consent?
Yes, digital consent forms are increasingly accepted, provided the platform used is secure, authenticates the identity of the signer, and complies with local regulations such as the eIDAS or ESIGN Act, depending on country-specific rules.
Regulatory Context
Verified Funding Bodies
Funder registries and DOI configurations verified for compliance in Brazil via Crossref.
- Governo BrasilID: 501100002425 | Location: Brazil
- Ministério da EducaçãoID: 501100006366 | Location: Brazil
- IBM Research – BrazilID: 100031474 | Location: Brazil
- Chevron Brazil Upstream Frade LtdaID: 100015145 | Location: Brazil
- Repsol Sinopec BrasilID: 100031804 | Location: Brazil
- Brazilian Microbiome ProjectID: 100018052 | Location: Brazil
- Instituto ButantanID: 100018798 | Location: Brazil
- Fundação Nacional de SaúdeID: 501100016062 | Location: Brazil
- Brazilian Institute of Neuroscience and NeurotechnologyID: 100032024 | Location: Brazil
- Sociedade Brasileira de DermatologiaID: 501100013994 | Location: Brazil
Pre-Submission Warning
Do not recruit participants or initiate study procedures before receiving official written approval from your reviewing board. Ethical approvals cannot be granted retrospectively under Resolution CNS 466/12 & Resolution CNS 510/16.
